| Enrollment | Allocation | CBT Suitability | Post-randomization | ||||
---|---|---|---|---|---|---|---|---|
TIME POINT | -t 1 | 0 | 0 | T 1 (Baseline) | T 2 (6 to 8 weeks postrandomization) | T 3 (3 months postpartum) | T 4 (6 months postpartum) | T 5 (12 months postpartum) |
ENROLLMENT: | Â | Â | Â | Â | Â | Â | Â | Â |
Eligibility screen (based on DASS21 and EPDS) | X | Â | Â | Â | Â | Â | Â | Â |
Informed consent | X | Â | Â | Â | Â | Â | Â | Â |
Allocation | Â | X | Â | Â | Â | Â | Â | Â |
Determination of suitability for CBT (based on ANRQ-R) | Â | Â | X | Â | Â | Â | Â | Â |
INTERVENTIONS: | Â | Â | Â | Â | Â | Â | Â | Â |
Psychosocial assessment (ANRQ-R) | Â | Â | Â | X | Â | Â | Â | Â |
Referral | Â | Â | Â | X | Â | Â | Â | Â |
Online cognitive behavior therapy | Â | Â | Â | X | X | Â | Â | Â |
ASSESSMENTS: | Â | Â | Â | Â | Â | Â | Â | Â |
Baseline variablesa | Â | Â | Â | X | Â | Â | Â | Â |
Primary outcome: Depression, anxiety, stress symptoms | X | Â | Â | X | X | Â | Â | Â |
Secondary outcomes -maternalb | Â | Â | Â | X | X | Â | Â | Â |
Secondary outcomes -maternal and infantc | Â | Â | Â | Â | Â | X | X | X |
Utility, usability, acceptability of intervention | Â | Â | Â | Â | X | Â | Â | Â |
Phase 2: Qualitative interviews | Â | Â | Â | Â | X | X | X | Â |